Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-11-28T07:04:16.140Z Has data issue: false hasContentIssue false
  • English
  • Français

Open heart surgery without homologous blood transfusion and subsequent use of recombinant erythropoietin to treat postoperative anemia

Published online by Cambridge University Press:  19 August 2008

Michael Vogel ,
Antje Kirchhoff ,
Konrad Bühlmeyer  and
François Bourlon
Michael Vogel*
Affiliation:
From the Klinik für Herz-und Kreislaufkrankheiten im Kindesalter am Deutschen Herzzentrum München, Monaco
Antje Kirchhoff
Affiliation:
From the Klinik für Herz-und Kreislaufkrankheiten im Kindesalter am Deutschen Herzzentrum München, Monaco
Konrad Bühlmeyer
Affiliation:
From the Klinik für Herz-und Kreislaufkrankheiten im Kindesalter am Deutschen Herzzentrum München, Monaco
François Bourlon
Affiliation:
Centre Cardiothoracique, Monaco
*
Priv.-Doz. Dr. Michael Vogel, Kinderkardiologie am Deutschen Herzzentrum München, Lothstr. 11, D-80335 München, Germany. Tel. 49 89 1209 450; Fax. 49 89 1209 547.
Get access Rights & Permissions [Opens in a new window]

Summary

The purpose of our study was to assess the effect of administration of erythropoietin on postoperative anemia in patients with congenital heart disease who had undergone open heart surgery without the use of homologous blood. One intravenous and one subcutaneous dose of 300 units of erythropoietin per kg body weight was given to 10 patients at a mean of five (3–8) days after surgery. Another group of 10 patients, who had undergone open heart surgery but were not given erythropoietin postoperatively, were used as controls. There was a significant fall in all patients in hemoglobin from 13.6±1.3 gm/dl prior to surgery to 9.8±1.6 gm/dl after surgery. In patients treated with erythropoietin, there was an immediate significant rise in hemoglobin and hematocrit. Hemoglobin rose by 14% on the seventh day after treatment (the twelfth day after surgery) and by 25% on the tenth day after treatment (the fifteenth day after surgery). It had increased by only 8% 15 days after surgery in the controls. These findings suggest a beneficial effect of administration of recombinant erythropoietin on postoperative anemia in children who had undergone open heart surgery without the use of homologous blood.

Keywords

Erythropoietinpostoperative anemiacongenital heart disease
Type
Original Articles
Information
Cardiology in the Young , Volume 5 , Issue 2 , April 1995 , pp. 118 - 121
Copyright
Copyright © Cambridge University Press 1995

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Pineda, AA, Brzica, SM, Tarweli, HF.Hemolytic transfusion reaction: Recent experience in a large blood bank. Mayo Clin Proc 1978; 53: 378–390.Google Scholar
2.Juji, T, Takahashi, K, Shibata, Y, Ide, H, Sakakibara, T, Ino, T, Mori, S.Post-transfusion graft-versus-host disease in immunocompetent patients after cardiac surgery in Japan. N EngI J Med 1989; 321: 56.Google ScholarPubMed
3.Wick, MR, Moore, S, Tasweli, HF.Non-A non-B hepatitis associated with blood transfusion. Transfusion 1985; 25: 93–101.CrossRefGoogle ScholarPubMed
4.Schorr, JB, Berkowitz, A, Cumming, PD, Katz, AJ, Sandler, SG.Prevalence of HTLV-lIl antibody in American blood donors. N Engl J Med 1985; 53: 384–385.Google Scholar
5.Britton, LW, Eastlund, DT, Dziuban, SW, Foster, ED, Mellduff, JB, Canavan, TE, Older, TM.Predonated autologous blood use in elective cardiac surgery. Ann Thorac Surg 1989; 47: 529–532.CrossRefGoogle ScholarPubMed
6.Esbach, JW, Egrie, JC, Downing, MR, Brown, JK., Adamson, JW.Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. N Engl J Med 1987; 316: 73–78.CrossRefGoogle Scholar
7.Blackburn, MEC, Kendall, RG, Gibbs, JL, Dickinson, DF, Parsons, JM, Norfolk, DR.Anemia in children following cardiac transplantation: treatment with low dose human recombinant erythropoietin. Inter J Cardiol 1992; 36:263–266.CrossRefGoogle ScholarPubMed
8.Kyo, S, Omoto, R, Hirashima, K, Eguchi, S, Fujita, T.Effect of human recombinant erythropoietin on reduction of homologous blood transfusion in open-heart surgery. Circulation 1992; 86 (Supp IIyes): II413–II418.Google ScholarPubMed
9.Watanabe, Y, Fuse, K, Naruse, Y, Kobayasi, T, Yamamoto, S, Konishi, H, Horii, T, Shibata, Y.Subcutaneous use of erythropoietin in heart surgery. Ann Thorac Surg 1992; 54:479–483.CrossRefGoogle ScholarPubMed
10.Watanabe, Y, Fuse, K, Konishi, T, Kobayasi, T, Takazawa, K, Konishi, H, Shibata, Y.Autologous blood transfusion with recombinant human erytrhopoietin in heart operations. Ann Thorac Surg 1991; 51: 767–772.CrossRefGoogle Scholar